Development of a City-Wide Cohort of HIV-Infected Persons in Care in the District of Columbia: the DC Cohort

Recruiting

• Conditions: HIV; AIDS

• Registration Number: NCT01206920
• Lead Sponsor: George Washington University

Brief Summary

The goal of the DC Cohort is to establish a clinic-based city-wide longitudinal cohort that will describe clinical outcomes, and improve the quality of care for outpatients with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) in Washington, DC.

Detailed Description

All major community and academic clinics treating HIV-infected persons in the District of Columbia (DC) will initially be included in the development of a city-wide "DC Cohort" of HIV-infected persons in care, with consideration to be given subsequently to the inclusion of large private physician practices. Socio-demographics, risk factors, treatments, diagnoses, labs and procedures documented in outpatient medical record systems will be included in the DC Cohort database. Routine reports will be generated every six months for sites comparing their participants' socio-demographics, clinical status, treatments, and outcomes to all other data in the DC Cohort database, and other comparisons specifically requested by sites. All sites will be provided analytic support in research areas of interest.

Study Timeline

• Study First Submitted: 2010-09-21
• Study First Submitted QC: 2010-09-21
• Study First Posted: 2010-09-22
• Study Start: 2011-01
• Status Verified: 2023-10
• Last Update Submitted: 2024-10-23
• Last Update Posted: 2024-10-26
• Primary Completion: 2041-01
• Study Completion: 2041-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 15000

Inclusion Criteria

• Patient is receiving care for HIV at one or more of the twelve participating clinics in the DC Cohort.
• Patient is either age 18 years or older, or seeks HIV care independently and is able to understand and sign informed consent.
• Patient is a minor who is consented by a parent or legal guardian.

Exclusion Criteria

• Patient is unable or refuses to provide informed consent.
• Minor children ages 12 through 17 who are unaware of their HIV status

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Following the health of those with HIV throughout the study	duration of cohort

Trial Locations

Locations (14)

Kaiser Permanente Mid-Atlantic States; 🇺🇸 Washington, District of Columbia, United States

Unity Health Care; 🇺🇸 Washington, District of Columbia, United States

MetroHealth; 🇺🇸 Washington, District of Columbia, United States

Georgetown University; 🇺🇸 Washington, District of Columbia, United States

La Clinica Del Pueblo; 🇺🇸 Washington, District of Columbia, United States

Whitman-Walker Health; 🇺🇸 Washington, District of Columbia, United States

Children's National Medical Center--Pediatric Clinic; 🇺🇸 Washington, District of Columbia, United States

Washington Hospital Center; 🇺🇸 Washington, District of Columbia, United States

Washington Health Institute; 🇺🇸 Washington, District of Columbia, United States

Family and Medical Counseling Service; 🇺🇸 Washington, District of Columbia, United States

George Washington Medical Faculty Associates; 🇺🇸 Washington, District of Columbia, United States

Howard University Hospital--Adult Clinic; 🇺🇸 Washington, District of Columbia, United States

Howard University Hospital--Pediatric Clinic; 🇺🇸 Washington, District of Columbia, United States

Veterans Affairs Medical Center; 🇺🇸 Washington, District of Columbia, United States